Gp120 V5 Is Targeted by the First Wave of Sequential Neutralizing Antibodies in SHIVSF162P3N -Infected Rhesus Macaques

Viruses
Manxue JiaXueling Wu

Abstract

Simian-human immunodeficiency virus (SHIV) infection provides a relevant animal model to study HIV-1 neutralization breadth. With previously identified SHIVSF162P3N infected rhesus macaques that did or did not develop neutralization breadth, we characterized the transmitted/founder viruses and initial autologous/homologous neutralizing antibodies in these animals. The plasma viral load and blood CD4 count did not distinguish macaques with and without breadth, and only one tested homologous envelope clone revealed a trend for macaques with breadth to favor an early homologous response. In two macaques with breadth, GB40 and FF69, infected with uncloned SHIVSF162P3N, multiple viral variants were transmitted, and the transmitted variants were not equal in neutralization sensitivity. The targets of initial autologous neutralizing antibodies, arising between 10 and 20 weeks post infection, were mapped to N462 glycan and G460a in gp120 V5 in GB40 and FF69, respectively. Although it is unclear whether these targets are related to later neutralization breadth development, the G460a target but not N462 glycan appeared more common in macaques with breadth than those without. Longitudinal plasmas revealed 2⁻3 sequential waves of neutraliz...Continue Reading

References

Mar 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Douglas D RichmanChristos J Petropoulos
Mar 21, 2003·Nature·Xiping WeiGeorge M Shaw
Jun 1, 2007·Journal of Virology·Siu-hong HoCecilia Cheng-Mayer
May 21, 2008·Proceedings of the National Academy of Sciences of the United States of America·Brandon F KeeleGeorge M Shaw
Sep 19, 2009·PLoS Pathogens·Penny L MooreUNKNOWN NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI)
Nov 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·Laura M WalkerDennis R Burton
Jun 8, 2012·Cold Spring Harbor Perspectives in Medicine·Jeffrey D Lifson, Nancy L Haigwood
Jun 29, 2012·Journal of Virology·Madina ShakirzyanovaCecilia Cheng-Mayer
Oct 9, 2012·Cold Spring Harbor Perspectives in Medicine·George M Shaw, Eric Hunter
Nov 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Masashi ShingaiMalcolm A Martin
Dec 12, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Alexandra MumbauerCecilia Cheng-Mayer
Mar 30, 2013·Science·Joseph JardineWilliam R Schief
Apr 5, 2013·Nature·Hua-Xin LiaoBarton F Haynes
Jun 19, 2013·Immunological Reviews·John R Mascola, Barton F Haynes
Aug 24, 2013·Nature Reviews. Immunology·Peter D KwongGary J Nabel
Oct 18, 2013·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar
Mar 5, 2014·Nature·Nicole A Doria-RoseJohn R Mascola
May 20, 2015·Nature Immunology·Dennis R Burton, John R Mascola
Sep 30, 2015·AIDS·Keshet RonenJulie Overbaugh
Apr 27, 2016·Cell·Guillaume B E Stewart-JonesPeter D Kwong
Jun 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Hui LiGeorge M Shaw
Mar 17, 2017·Science Translational Medicine·Mattia BonsignoriBarton F Haynes
Mar 25, 2017·Retrovirology·Samuel Mundia KariukiJeffrey R Dorfman

❮ Previous
Next ❯

Methods Mentioned

BETA
PCRs
PCR
SGA
glycosylation

Software Mentioned

DNAdist
ClustalW
GraphPad
BioEdit
Prism

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.